Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Group 1 – Healthy volunteers (for MRI development):
- Healthy male volunteers aged 18 or older with no history of prostate cancer
- Willing to be contacted if something unexpected is found during the scan
- Able to provide signed consent to participate
Group 2 – Men with metal implants:
- Adult men aged 18 or older who have had a 3T MRI prostate scan that could not produce clear enough results because of metal implants in the body
- Able to provide signed consent to participate
Group 3 – Men with suspicious findings on a prostate scan:
- Adult men aged 18 or older who have had a 3T MRI showing a suspicious area on the prostate (rated PI-RADS 4 or 5, which means a finding that doctors consider worth investigating further), and who are already scheduled for a targeted biopsy
- Able to provide signed consent to participate
Who may not be able to join:
Group 1 – Healthy volunteers:
- People with a personal history of prostate cancer
- People with any safety reasons that would make an MRI scan unsuitable for them (confirm with trial site)
Group 2 – Men with metal implants:
- People for whom the treating doctor identifies medical reasons that make participation unsuitable
- People with any condition that makes them unsuitable for the study (confirm with trial site)
- People who are not willing to be informed if something unexpected is found on their scan
Group 3 – Men with suspicious findings:
- People with a personal history of prostate cancer
- People for whom the treating doctor identifies medical reasons that make participation unsuitable
- People with any condition that makes them unsuitable for the study (confirm with trial site)
- People who are not willing to be informed if something unexpected is found on their scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ileana Jelescu, Prof, University of Lausanne Hospitals
Phone: 0795560240
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate the diagnostic accuracy of 0.55T MRI in detecting prostate suspicious lesions using the PI-RADS grading score, with the results of as the reference standard.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.